Gabrielle Kornmann

Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy

Magnhild Sandberg‐Wollheim, Enrica Alteri, Margaretha Stam Moraga et al. · Multiple Sclerosis Journal · 2011 · 123 citations · Full text

Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study

Hans-Peter Hartung, Bruce Cree, Maria Pia Sormani et al. · Multiple Sclerosis Journal · 2021 · 75 citations · Full text

The risk of malignancy is not increased in patients with multiple sclerosis treated with subcutaneous interferon beta-1a: analysis of data from clinical trial and post-marketing surveillance settings

Magnhild Sandberg‐Wollheim, Gabrielle Kornmann, Dorina Bischof et al. · Multiple Sclerosis Journal · 2011 · 31 citations · Full text

Temelimab, an IgG4 Anti-Human Endogenous Retrovirus Monoclonal Antibody: An Early Development Safety Review

Gabrielle Kornmann, François Curtin · Drug Safety · 2020 · 18 citations

Human Retrovirus, Immunology, Antiviral Response +6

A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetes

François Curtin, Bernard Champion, Peter Davoren et al. · Diabetes Obesity and Metabolism · 2020 · 16 citations · Full text